Advertisement

Topics

FDA Drug and Biologic Approvals for Neurology: 2017 Midyear Review

05:00 EDT 11 Aug 2017 | Neurology Times

Seven new drugs were approved for treatment of neurological disorders, including Parkinson disease, multiple sclerosis, and amyotrophic lateral sclerosis.

Original Article: FDA Drug and Biologic Approvals for Neurology: 2017 Midyear Review

NEXT ARTICLE

More From BioPortfolio on "FDA Drug and Biologic Approvals for Neurology: 2017 Midyear Review"

Quick Search
Advertisement
 

Relevant Topic

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...